Search Results

Displaying Results 1-19 of 19 "'EHAB'"
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
CellCarta and Sonic Healthcare Establish Strategic Partnership to Commercialize Companion Diagnostics Through Lab Network

May 27, 2026, 11:11 ET CellCarta and Sonic Healthcare Establish Strategic Partnership to Commercialize Companion Diagnostics Through Lab Network

physician and patient access.""Too often, single-site CDx strategies are perceived as limiting patient reach," said Ehab A. El-Gabry, MD, Chief Medical Officer and Head of Companion Diagnostics at CellCarta. "This model is different. We support sponsors end-to-end—from

More news about: CellCarta

Beyond the Millimeter: NaoTrac Redefines Precision Standards via Intelligent Surgical Navigation

May 26, 2026, 09:00 ET Beyond the Millimeter: NaoTrac Redefines Precision Standards via Intelligent Surgical Navigation

https://mma.prnewswire.com/media/2987519/Prof__Dr__med__Ehab_Shiban___NaoTrac.jpg

More news about: Brain Navi Biotechnology

Are CCO, <em>EHAB,</em> APLS, VRE Obtaining Fair Deals for their Shareholders?

Apr 20, 2026, 18:59 ET Are CCO, EHAB, APLS, VRE Obtaining Fair Deals for their Shareholders?

multimedia:https://www.prnewswire.com/news-releases/are-cco-ehab-apls-vre-obtaining-fair-deals-for-their-shareholders-302747811.htmlSOURCE

More news about: Halper Sadeh LLP

Are <em>EHAB,</em> UNF, SNCY, ESQ Obtaining Fair Deals for their Shareholders?

Apr 16, 2026, 14:21 ET Are EHAB, UNF, SNCY, ESQ Obtaining Fair Deals for their Shareholders?

multimedia:https://www.prnewswire.com/news-releases/are-ehab-unf-sncy-esq-obtaining-fair-deals-for-their-shareholders-302745073.htmlSOURCE

More news about: Halper Sadeh LLP

$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--WSR, ASRT, <em>EHAB,</em> and SEM

Apr 15, 2026, 15:09 ET $HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--WSR, ASRT, EHAB, and SEM

EHAB) related to its sale to Kinderhook Industries, LLC. Under the terms of the proposed transaction, Enhabit shareholders are expected to receive

More news about: Monteverde & Associates PC

Kansas City University students and alumni earn honors in osteopathic medicine and biology

Apr 08, 2026, 08:08 ET Kansas City University students and alumni earn honors in osteopathic medicine and biology

here.Student Doctor Ekin's work is the subject of a pending NIIH R21 grant application on pancreatic cancer therapy from the research lab of Ehab Sarsour, MSc, PhD, associate professor of cellular and molecular biology and biochemistry at KCU-COM.  The research is conducted in collaboration with

More news about: Kansas City University

Are <em>EHAB,</em> SLAB, PEN, SKYT Obtaining Fair Deals for their Shareholders?

Mar 31, 2026, 11:19 ET Are EHAB, SLAB, PEN, SKYT Obtaining Fair Deals for their Shareholders?

multimedia:https://www.prnewswire.com/news-releases/are-ehab-slab-pen-skyt-obtaining-fair-deals-for-their-shareholders-302730243.htmlSOURCE

More news about: Halper Sadeh LLP

SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--SLAB, PEN, SKYT, and <em>EHAB</em>

Mar 30, 2026, 13:35 ET SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--SLAB, PEN, SKYT, and EHAB

EHAB) related to its sale to Kinderhook Industries, LLC. Under the terms of the proposed transaction, Enhabit shareholders are expected to receive

More news about: Monteverde & Associates PC

Lunit, CellCarta Announce Strategic Collaboration to Accelerate AI-Enabled Digital Pathology for Companion Diagnostic Programs

Mar 30, 2026, 03:15 ET Lunit, CellCarta Announce Strategic Collaboration to Accelerate AI-Enabled Digital Pathology for Companion Diagnostic Programs

to strengthen how biopharma teams generate actionable tissue biomarker evidence and prepare for regulatory and commercialization requirements," said Ehab A. El-Gabry, MD, Chief Medical Officer and Head of Companion Diagnostics at CellCarta.The companies expect to begin with jointly selected pilot

More news about: Lunit

Are EWCZ, KORE, <em>EHAB</em> Obtaining Fair Deals for their Shareholders?

Mar 27, 2026, 05:54 ET Are EWCZ, KORE, EHAB Obtaining Fair Deals for their Shareholders?

multimedia:https://www.prnewswire.com/news-releases/are-ewcz-kore-ehab-obtaining-fair-deals-for-their-shareholders-302727049.htmlSOURCE

More news about: Halper Sadeh LLP

SHAREHOLDER ALERT: The M&A Class Action Firm Encourages Shareholders to Act Before the Vote--SWKH, COUR, JHG, and <em>EHAB</em>

Mar 20, 2026, 16:08 ET SHAREHOLDER ALERT: The M&A Class Action Firm Encourages Shareholders to Act Before the Vote--SWKH, COUR, JHG, and EHAB

EHAB) related to its sale to Kinderhook Industries, LLC. Under the terms of the proposed transaction, Enhabit shareholders are expected to receive

More news about: Monteverde & Associates PC

SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--ACLX, VRE, <em>EHAB,</em> and CECO

Mar 04, 2026, 14:10 ET SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--ACLX, VRE, EHAB, and CECO

EHAB) related to its sale to Kinderhook Industries, LLC. Under the terms of the proposed transaction, Enhabit shareholders are expected to receive

More news about: Monteverde & Associates PC

Are <em>EHAB,</em> DVN, LNKB, CECO Obtaining Fair Deals for their Shareholders?

Mar 03, 2026, 15:13 ET Are EHAB, DVN, LNKB, CECO Obtaining Fair Deals for their Shareholders?

multimedia:https://www.prnewswire.com/news-releases/are-ehab-dvn-lnkb-ceco-obtaining-fair-deals-for-their-shareholders-302702828.htmlSOURCE

More news about: Halper Sadeh LLP

CellCarta Appoints <em>Ehab</em> A. El-Gabry, MD, as Chief Medical Officer & Head of Companion Diagnostics to Advance CDx Strategy, Digital Pathology and AI

Mar 03, 2026, 08:10 ET CellCarta Appoints Ehab A. El-Gabry, MD, as Chief Medical Officer & Head of Companion Diagnostics to Advance CDx Strategy, Digital Pathology and AI

Ehab A. El-Gabry, MD, as Chief Medical Officer and Head of Companion Diagnostics. In this role, Dr. El-Gabry will provide medical and scientific

More news about: CellCarta

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Enhabit Inc. (NYSE: <em>EHAB)</em>

Feb 24, 2026, 13:27 ET $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Enhabit Inc. (NYSE: EHAB)

EHAB) related to its sale to Kinderhook Industries, LLC. Under the terms of the proposed transaction, Enhabit shareholders are expected to receive $13.80

More news about: Monteverde & Associates PC

Are ACLX, VRE, UHG, <em>EHAB</em> Obtaining Fair Deals for their Shareholders?

Feb 23, 2026, 17:22 ET Are ACLX, VRE, UHG, EHAB Obtaining Fair Deals for their Shareholders?

multimedia:https://www.prnewswire.com/news-releases/are-aclx-vre-uhg-ehab-obtaining-fair-deals-for-their-shareholders-302694886.htmlSOURCE

More news about: Halper Sadeh LLP

Shareholder Alert: The Ademi Firm investigates whether Enhabit Inc. is obtaining a Fair Price for its Public Shareholders

Feb 23, 2026, 12:25 ET Shareholder Alert: The Ademi Firm investigates whether Enhabit Inc. is obtaining a Fair Price for its Public Shareholders

MILWAUKEE, Feb. 23, 2026 /PRNewswire/ -- Ademi LLP is investigating Enhabit (NYSE: EHAB) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Kinderhook Industries.

More news about: Ademi LLP

ABS Bio Acquires Cureline, Broadening Access to Biospecimens & Streamlining Execution from End to End

Jan 06, 2026, 08:30 ET ABS Bio Acquires Cureline, Broadening Access to Biospecimens & Streamlining Execution from End to End

Area."Cureline has built an exceptional reputation in the biospecimens and research space, and we are excited to welcome their team to ABS," says Ehab Alramahy, CEO of ABS Bio. "This acquisition meaningfully expands our capacity and expertise while enabling us to remain focused on what matters most

More news about: 3 Boomerang Capital

ABS Bio Appoints <em>Ehab</em> Alramahy as President & CEO

Jul 09, 2025, 08:30 ET ABS Bio Appoints Ehab Alramahy as President & CEO

Ehab Alramahy to this important role," said John Chickosky, Executive Chairman of ABS Bio. "In our search for a successor, we prioritized deep domain expertise and a leadership style that reflects ABS Bio's client-first culture. Ehab brings both to

More news about: 3 Boomerang Capital; ABS Bio

Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.